In routine health check-up settings, measurement of serum ANGPTL4 may, pending external validation, serve as a complementary screening aid to identify individuals with possible glucose intolerance, given its practical convenience in clinical workflows. The gene discussed is ANGPTL4; the disease is Glucose intolerance.